Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.

Cellular immunology - 25 May 1996

Gabrilovich D I, Ciernik I F, Carbone D P

Abstract excerpt

Induction of specific antitumor cytotoxic T cell responses was studied in BALB/c mice bearing tumors transfected with a mutant human p53 minigene. We observed that mice were resistant to the induction of peptide-specific CTL as early as 5 days after challenge with a minimal lethal dose of tumor c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Base Sequence
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Inbred BALB C

Share to Mice, Inbred C57BL

Share to Molecular Sequence Data

Share to Mutation

Source

Identifiers

PMID: 8665590
DOI: 10.1006/cimm.1996.0139

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-8665590-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.PMID 8665590Read ↗

IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer.Semantic proximity Read ↗

Cellular Immunotherapy with Dendritic Cells in Cancer: Current StatusSemantic proximity Read ↗

Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.Semantic proximity Read ↗

Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation.Semantic proximity Read ↗

DNA vaccination with a mutated p53 allele induces specific cytolytic T cells and protects against tumor cell growth and the formation of metastasis.Semantic proximity Read ↗

Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.Semantic proximity Read ↗

Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity.Semantic proximity Read ↗

Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands.Semantic proximity Read ↗

Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.Semantic proximity Read ↗

CD4+ T cell responses to self- and mutated p53 determinants during tumorigenesis in mice.Semantic proximity Read ↗

Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge.Semantic proximity Read ↗

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.